In vivo effects of glycyl-glutamate and glycyl-sarcosine on gabapentin oral absorption in rat.

Abstract:

PURPOSE:The objective of this study was to evaluate the in vivo consequences of glycyl-glutamate coadministration on gabapentin oral absorption. METHODS:Rats were administered gabapentin (10 mg/kg plus radiotracer) by gastric gavage, in the absence and presence of dipeptides, and by intravenous administration. Serial blood samples were obtained over 6 h and the pharmacokinetics of gabapentin were determined by noncompartmental analysis. RESULTS:Glycyl-glutamate coadministration increased the Cmax of gabapentin by 86% as compared to gabapentin alone. In agreement, the oral absorption of gabapentin, relative to the intravenous dose, was 79% after glycyl-glutamate loading but only 47% when drug was administered alone. However, when glycyl-sarcosine was added to the orally administered admixture of gabapentin plus glycyl-glutamate, values for Cmax and AUC(0-6 h) reverted back to that of control. In contrast, the tmax and terminal half-life of gabapentin did not change after oral dosing for all treatments. CONCLUSIONS:These findings are unique in demonstrating that under physiologic, in vivo conditions, the luminal presence of glycyl-glutamate could dramatically enhance the Cmax and AUC(0-6 h) of gabapentin. The results are consistent with previous in situ intestinal perfusion studies in rat, and establish a functional interaction between the activities of PEPT1 and amino acid exchangers.

journal_name

Pharm Res

journal_title

Pharmaceutical research

authors

Nguyen TV,Fleisher D,Smith DE

doi

10.1007/s11095-007-9272-x

subject

Has Abstract

pub_date

2007-08-01 00:00:00

pages

1538-43

issue

8

eissn

0724-8741

issn

1573-904X

journal_volume

24

pub_type

杂志文章
  • Intra- and intersubject variability: mixed-effects statistical analysis of repeated doses of an angiotensin converting enzyme inhibitor, CGS 16617.

    abstract::The intrasubject and intersubject variabilities for CGS 16617, an angiotensin converting enzyme inhibitor, were evaluated in an open-label, repeat single-dose bioavailability trial. Eight healthy male volunteers each received a 20-mg oral dose of CGS 16617 as an aqueous solution on four separate occasions. Components ...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1023/a:1015954609527

    authors: Kochak GM,Smith RA,Choi RL,John V,Tipnis V,Honc F,deSilva JK,Weidler DJ

    更新日期:1989-04-01 00:00:00

  • Targeting of liposomes via PSGL1 for enhanced tumor accumulation.

    abstract:PURPOSE:To improve the delivery of liposomes to tumors using P-selectin glycoprotein ligand 1 (PSGL1) mediated binding to selectin molecules, which are upregulated on tumorassociated endothelium. METHODS:PSGL1 was orientated and presented on the surface of liposomes to achieve optimal selectin binding using a novel st...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1007/s11095-012-0875-5

    authors: Carlisle R,Seymour LW,Coussios CC

    更新日期:2013-02-01 00:00:00

  • Investigation into the influence of primary crystallization conditions on the mechanical properties and secondary processing behaviour of fluticasone propionate for carrier based dry powder inhaler formulations.

    abstract:PURPOSE:To investigate the influence of primary crystallization conditions on the mechanical properties and secondary processing behaviour of fluticasone propionate (FP) for carrier based dry powder inhaler (DPI) formulations. METHODS:Young's modulus of FP crystals produced using different anti-solvents was determined...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1007/s11095-011-0640-1

    authors: Kubavat HA,Shur J,Ruecroft G,Hipkiss D,Price R

    更新日期:2012-04-01 00:00:00

  • Accumulation kinetics of propranolol in the rat: comparison of Michaelis-Menten-mediated clearance and clearance changes consistent with the "altered enzyme hypothesis".

    abstract::(+)-Propranolol was infused at two rates into the pyloric vein (a portal vein tributary) of 15 male Sprague Dawley rats until apparent steady-state conditions were established (i.e., 8 hr at each rate). One group (n = 7) received the high dose (40 micrograms/min/kg) first, and in the other group (n = 8) the low dose (...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1023/a:1018921306200

    authors: Weber C,Stoeckel K,Lalka D

    更新日期:1994-03-01 00:00:00

  • A Radioimmunoassay Procedure for the Determination of the Antiviral Nucleoside DHPG (9-[(l,3-Dihydroxy-2-propoxy)-methyl]guanine) in Plasma or Serum.

    abstract::A procedure is described that is suitable for the radioimmunoassay (RIA) of 9-[(l,3-dihydroxy-2-propoxy)-methyl]guanine (DHPG) in plasma or serum at concentrations as low as 0.7 ng/ml (2.75 × 10(-9) M). Antiserum was prepared by coupling DHPG monohemisuccinate to bovine serum albumin and immunizing rabbits with the re...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1023/A:1016397520991

    authors: Nerenberg C,McClung S,Martin J,Fass M,La Fargue J,Kushinsky S

    更新日期:1986-04-01 00:00:00

  • Initial Drug Dissolution from Amorphous Solid Dispersions Controlled by Polymer Dissolution and Drug-Polymer Interaction.

    abstract:PURPOSE:To identify the key formulation factors controlling the initial drug and polymer dissolution rates from an amorphous solid dispersion (ASD). METHODS:Ketoconazole (KTZ) ASDs using PVP, PVP-VA, HMPC, or HPMC-AS as polymeric matrix were prepared. For each drug-polymer system, two types of formulations with the sa...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1007/s11095-016-1969-2

    authors: Chen Y,Wang S,Wang S,Liu C,Su C,Hageman M,Hussain M,Haskell R,Stefanski K,Qian F

    更新日期:2016-10-01 00:00:00

  • In vivo bioequivalence and in vitro similarity factor (f2) for dissolution profile comparisons of extended release formulations: how and when do they match?

    abstract:PURPOSE:To investigate how likely two extended release formulations are to be bioequivalent when they demonstrate f2 similarity. METHOD:Dissolution profiles were simulated using the Weibull model and varying model parameters around those of a reference profile. The f2 values were calculated for the comparisons of each...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1007/s11095-011-0377-x

    authors: Duan JZ,Riviere K,Marroum P

    更新日期:2011-05-01 00:00:00

  • In vitro gastrointestinal lipolysis of four formulations of piroxicam and cinnarizine with the self emulsifying excipients Labrasol and Gelucire 44/14.

    abstract:PURPOSE:Labrasol and Gelucire 44/14 are defined admixtures of acylglycerols and PEG esters which are substrates for digestive lipases. METHODS:We investigated their in vitro gastrointestinal lipolysis to understand which compounds are, after digestion, responsible for keeping poorly water-soluble drugs in solution. Th...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1007/s11095-009-9906-2

    authors: Fernandez S,Chevrier S,Ritter N,Mahler B,Demarne F,Carrière F,Jannin V

    更新日期:2009-08-01 00:00:00

  • Jejunal absorption and metabolism of R/S-verapamil in humans.

    abstract:PURPOSE:The purpose of this human intestinal perfusion study was to investigate the transport and metabolism of R/S-verapamil in the human jejunum (in vivo). METHODS:A regional single-pass perfusion of the jejunum was performed using a Loc-I-Gut perfusion tube in 12 healthy volunteers. Each perfusion lasted for 200 mi...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1023/a:1011916329863

    authors: Sandström R,Karlsson A,Knutson L,Lennernäs H

    更新日期:1998-06-01 00:00:00

  • Competitive inhibition of glycylsarcosine transport by enalapril in rabbit renal brush border membrane vesicles: interaction of ACE inhibitors with high-affinity H+/peptide symporter.

    abstract:PURPOSE:To examine the inhibitory potential of enalapril [and other angiotensin converting enzyme (ACE) inhibitors] on glycylsarcosine (GlySar) transport by the high-affinity renal peptide transporter. METHODS:Studies were performed in rabbit renal brush border membrane vesicles in which the uptake of radiolabeled Gly...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1023/a:1018847818766

    authors: Lin CJ,Akarawut W,Smith DE

    更新日期:1999-05-01 00:00:00

  • Accurate determination of skin flux from flow-through diffusion cell data.

    abstract:PURPOSE:The goal of this investigation was to demonstrate whether the intrinsic flux of a drug diffusing across a membrane mounted in a flow-through diffusion cell may be accurately and easily determined by accounting for the accumulation in the receiver chamber. METHODS:Mathematical modeling, applied to transdermal d...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1023/a:1016216611809

    authors: Harrison DJ,Knutson K

    更新日期:1995-12-01 00:00:00

  • Crystal growth kinetics of theophylline monohydrate.

    abstract::The crystal growth kinetics of theophylline monohydrate from aqueous buffered supersaturated solutions were investigated at 10, 20, 30, and 40 degrees C. Crystallization experiments were carried out isothermally at pH 6. During growth the crystal count and size distributions were monitored in situ. The growth rate was...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1023/a:1015817109932

    authors: Rodríguez-Hornedo N,Wu HJ

    更新日期:1991-05-01 00:00:00

  • On technological and immunological benefits of multivalent single-injection microsphere vaccines.

    abstract:PURPOSE:With the aim of developing multivalent vaccines for single-injection, we examined the feasibility of combining antigens in biodegradable microspheres. Such vaccines are expected to improve vaccination coverage by reducing the number of vaccination sessions required to generate immunity. METHODS:Mono- and multi...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1023/a:1020354809581

    authors: Boehm G,Peyre M,Sesardic D,Huskisson RJ,Mawas F,Douglas A,Xing D,Merkle HP,Gander B,Johansen P

    更新日期:2002-09-01 00:00:00

  • Structural effects on the binding of amine drugs with the diphenylmethyl functionality to cyclodextrins. I. A microcalorimetric study.

    abstract::Solution calorimetry has been employed to evaluate the stability constants and enthalpy changes associated with complex formation between alpha-, beta, or gamma-cyclodextrin (CD) and a group of amine compounds having the diphenylmethyl functionality. Data from thermal titrations of the compounds were analyzed using no...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1023/a:1015880218535

    authors: Tong WQ,Lach JL,Chin TF,Guillory JK

    更新日期:1991-07-01 00:00:00

  • pGlu-L-Dopa-Pro: a tripeptide prodrug targeting the intestinal peptide transporter for absorption and tissue enzymes for conversion.

    abstract:PURPOSE:The purpose of this study is to investigate the characteristics of pGlu-L-Dopa-Pro as a prodrug of L-Dopa. METHODS:pGlu-L-Dopa-Pro and L-Dopa-Pro were synthesized using the standard procedures of peptide synthesis. The conversion of pGlu-L-Dopa-Pro to L-Dopa was studied using pyroglutamyl aminopeptidase I and ...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1023/a:1016239321494

    authors: Bai JP

    更新日期:1995-07-01 00:00:00

  • Intestinal absorption of miltefosine: contribution of passive paracellular transport.

    abstract:PURPOSE:This study aimed to characterize the transepithelial transport of miltefosine (HePC), the first orally effective drug against visceral leishmaniasis, across the intestinal barrier to further understand its oral absorption mechanism. MATERIALS AND METHODS:Caco-2 cell monolayers were used as an in vitro model of...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1007/s11095-006-9170-7

    authors: Ménez C,Buyse M,Dugave C,Farinotti R,Barratt G

    更新日期:2007-03-01 00:00:00

  • Manufacture and properties of erythromycin beads containing neutron-activated erbium-171.

    abstract::To evaluate the effects of a neutron activation radiolabeling technique on an enteric-coated multiparticulate formulation of erythromycin, test quantities were produced under industrial pilot scale conditions. The pellets contained the stable isotope erbium oxide (Er-170), which was later converted by neutron activati...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1023/a:1015826229323

    authors: Parr AF,Digenis GA,Sandefer EP,Ghebre-Sellassie I,Iyer U,Nesbitt RU,Scheinthal BM

    更新日期:1990-03-01 00:00:00

  • Immunopotentiator-Loaded Polymeric Microparticles as Robust Adjuvant to Improve Vaccine Efficacy.

    abstract:PURPOSE:Adjuvants are required to ensure the efficacy of subunit vaccines. Incorporating molecular immunopotentiators within particles could overcome drawbacks of molecular adjuvants (such as solubility and toxicity), and improve adjuvanticity of particles, achieving stronger adjuvant activity. Aim of this study is to ...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1007/s11095-015-1666-6

    authors: Zhang W,Wang L,Yang T,Liu Y,Chen X,Liu Q,Jia J,Ma G

    更新日期:2015-09-01 00:00:00

  • A Dose Ranging Pharmacokinetic Evaluation of IQP-0528 Released from Intravaginal Rings in Non-Human Primates.

    abstract:PURPOSE:Design of intravaginal rings (IVRs) for delivery of antiretrovirals is often guided by in vitro release under sink conditions, based on the assumption that in vivo release will follow a similar release profile. METHODS:We conducted a dose-ranging study in the female reproductive tract of pigtail macaques using...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1007/s11095-017-2224-1

    authors: Su JT,Teller RS,Srinivasan P,Zhang J,Martin A,Sung S,Smith JM,Kiser PF

    更新日期:2017-10-01 00:00:00

  • Nanocarriers.

    abstract::The use of nanoparticulate pharmaceutical carriers to enhance the in vivo efficiency of many drugs well established itself over the past decade both in pharmaceutical research and clinical setting. The current level of engineering pharmaceutical nanocarriers in some cases allows for drug delivery systems (DDS) to demo...

    journal_title:Pharmaceutical research

    pub_type: 社论

    doi:10.1007/s11095-007-9463-5

    authors: Torchilin VP

    更新日期:2007-12-01 00:00:00

  • Transdermal delivery of highly lipophilic drugs: in vitro fluxes of antiestrogens, permeation enhancers, and solvents from liquid formulations.

    abstract:PURPOSE:Highly lipophilic basic drugs, the antiestrogens AE 1 (log P = 5.82) and AE 2 (log P = 7.8) shall be delivered transdermally. METHODS:Transdermal permeation of drugs, enhancers, and solvents from various fluid formulations were characterized by in-vitro permeation studies through excised skin of hairless mice....

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1023/a:1015314314796

    authors: Funke AP,Schiller R,Motzkus HW,Günther C,Müller RH,Lipp R

    更新日期:2002-05-01 00:00:00

  • Surface modification of pharmaceutical nanocarriers with ascorbate residues improves their tumor-cell association and killing and the cytotoxic action of encapsulated paclitaxel in vitro.

    abstract:PURPOSE:To evaluate the potential of ascorbate as a novel ligand in the preparation of pharmaceutical nanocarriers with enhanced tumor-cell specific binding and cytotoxicity. METHODS:Palmitoyl ascorbate was incorporated into liposomes at varying concentrations. A stable formulation was selected based on size and zeta ...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1007/s11095-008-9674-4

    authors: D'Souza GG,Wang T,Rockwell K,Torchilin VP

    更新日期:2008-11-01 00:00:00

  • Enhanced bioavailability of L-carnitine after painless intradermal delivery vs. oral administration in rats.

    abstract:PURPOSE:In vitro and in vivo permeation studies were conducted to evaluate the characteristic of percutaneous administration of high hydrophilic drug L-carnitine (LC) by Functional MicroArray (FMA) painless intradermal delivery system. METHODS:In vitro study was designed to assess the effects of various skins, donor c...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1007/s11095-010-0109-7

    authors: Zhang S,Qin G,Wu Y,Gao Y,Qiu Y,Li F,Xu B

    更新日期:2011-01-01 00:00:00

  • Formulation and in vitro-in vivo evaluation of sustained-release lithium carbonate tablets.

    abstract::The release of lithium carbonate incorporated into polymethylmethacrylate, polyvinyl chloride, hydrogenated vegetable oil, and carbomer matrix tablets was studied in vitro. The formulation containing 10% carbomer showed a sustained-release profile comparable to that of a standard, commercially available, sustained-rel...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1023/a:1015863204732

    authors: Ciftçi K,Capan Y,Oztürk O,Hincal AA

    更新日期:1990-04-01 00:00:00

  • Natural Deep Eutectic Solvents as Agents for Improving Solubility, Stability and Delivery of Curcumin.

    abstract:PURPOSE:Study on curcumin dissolved in natural deep eutectic solvents (NADES) was aimed at exploiting their beneficial properties as drug carriers. METHODS:The concentration of dissolved curcumin in NADES was measured. Simulated gastrointestinal fluids were used to determine the concentration of curcumin and quantum c...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1007/s11095-019-2643-2

    authors: Jeliński T,Przybyłek M,Cysewski P

    更新日期:2019-06-03 00:00:00

  • Role of Knowledge Management in Development and Lifecycle Management of Biopharmaceuticals.

    abstract::Knowledge Management (KM) is a key enabler for achieving quality in a lifecycle approach for production of biopharmaceuticals. Due to the important role that it plays towards successful implementation of Quality by Design (QbD), an analysis of KM solutions is needed. This work provides a comprehensive review of the in...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章,评审

    doi:10.1007/s11095-016-2043-9

    authors: Rathore AS,Garcia-Aponte OF,Golabgir A,Vallejo-Diaz BM,Herwig C

    更新日期:2017-02-01 00:00:00

  • Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery.

    abstract:PURPOSE:The objective of this study was to develop and characterize long-circulating, biodegradable, and biocompatible nanoparticulate formulation as an intracellular delivery vehicle. METHODS:Poly(ethylene glycol) (PEG)-modified gelatin was synthesized by reacting Type-B gelatin with PEG-epoxide. The nanoparticles, p...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1023/a:1016486910719

    authors: Kaul G,Amiji M

    更新日期:2002-07-01 00:00:00

  • Impact of novel MDR modulators on human cancer cells: reversal activities and induction studies.

    abstract:PURPOSE:Novel multidrug resistance (mdr) modulators have been proved as inhibitors of P-glycoprotein (P-gp). We first investigated the in vitro effects of selected compounds in human cancer cells on multidrug resistance reversal effects compared to drug standards and on P-gp induction to characterize the potential of t...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1007/s11095-008-9736-7

    authors: Coburger C,Lage H,Molnár J,Hilgeroth A

    更新日期:2009-01-01 00:00:00

  • Trial and error: how the unclonable human mitochondrial genome was cloned in yeast.

    abstract:PURPOSE:Development of a human mitochondrial gene delivery vector is a critical step in the ability to treat diseases arising from mutations in mitochondrial DNA. Although we have previously cloned the mouse mitochondrial genome in its entirety and developed it as a mitochondrial gene therapy vector, the human mitochon...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1007/s11095-011-0527-1

    authors: Bigger BW,Liao AY,Sergijenko A,Coutelle C

    更新日期:2011-11-01 00:00:00

  • Liposomal induction of a heat-stable macrophage priming factor to induce nitric oxide in response to LPS.

    abstract:PURPOSE:The effects of liposomes on nitric oxide (NO) production from mouse peritoneal macrophages following intraperitoneal injection of liposomes were investigated. METHODS:Mouse peritoneal macrophages were collected following intraperitoneal injection of liposomes and cultured with and without lipopolysaccharide (L...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1023/a:1016034303012

    authors: Aramaki Y,Arima H,Hara T,Tsuchiya S

    更新日期:1996-09-01 00:00:00